Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.72−0.02 (-2.78%)
Close on Nov 18, 2026Market cap $66.69MP/E –Yield –
Anavex Life Sciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Anavex Life Sciences's price to book ratio was 0.9× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.9× to 9.7×, with a median of 4.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −2.4 |
| 2025 | Dec 31, 2025 | 3.3× | −4.3 |
| 2024 | Dec 31, 2024 | 7.6× | +2.2 |
| 2023 | Dec 29, 2023 | 5.4× | +0.3 |
| 2022 | Dec 30, 2022 | 5.1× | −3.7 |
| 2021 | Dec 31, 2021 | 8.7× | −3.6 |
| 2020 | Dec 31, 2020 | 12.3× | +5.6 |
| 2019 | Dec 31, 2019 | 6.7× | +3.5 |
| 2018 | Dec 31, 2018 | 3.2× | −2.2 |
| 2017 | Dec 29, 2017 | 5.4× | −17.3 |
| 2016 | Dec 30, 2016 | 22.7× | +8.8 |
| 2015 | Dec 31, 2015 | 13.9× | −32.6 |
| 2014 | Dec 31, 2014 | 46.6× | – |
See a number that looks wrong?